ETON 8-K 2026-10-14

Eton Pharmaceuticals, Inc. (ETON) 8-K dated 2026-10-14 — accession 0001437749-26-032600. This URL is the filing, not the ETON hub.

Eton Pharmaceuticals, Inc. (ETON) is a drug manufacturers - specialty & generic company listed on US.

Eton Pharmaceuticals, Inc. filed a 8-K on 2026-10-14. Accession 0001437749-26-032600.

Cached items: 1.01, 2.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ETON revenue for 2025-12-31 was $80.0M. Net income was -$4.6M. Revenue was up 104.9% from 2024-12-31 to 2025-12-31. ETON currently screens at market cap $797.9M.

Not investment advice. The ETON SEC hub lists recent forms. The stock page is the research view.